Results 51 to 60 of about 604 (128)

Proximal 4p Deletion Syndrome in an Infant With Multiple Systemic Anomalies

Molecular Genetics &Genomic Medicine, Volume 12, Issue 9, September 2024.
Karyotypic analysis of chromosome G‐banding in proband: 46, XY, del (4) (p15.33‐ p14). ABSTRACT Background Contiguous gene deletion in the short arm of chromosome 4 is linked to various neurodevelopmental disorders. Methods In this study, we conducted peripheral blood chromosome G‐banding karyotyping and whole‐exome sequencing (WES) on a proband ...
Ying Pang, Lan Zeng, Hua Liang, Chunlan Cheng, Lihui Shan, Jin Wang, Nanjing Jiang, Guanghuan Pi, Li Yang, Ai Chen, Fu Xiong, Shuyao Zhu   +11 more
wiley   +1 more source

Gating strategy for B-cell subsets’ identification.

, 2016
Dot plots on blue background identify subpopulations from the antibody backbone. HG 1: hematogones stage 1, HG 2: hematogones stage 2, IMM B: immature B cells, TR B: transitional B cells, N B: naive B cells, GC B: germinal center B cells, M B: memory B ...
Jean-Yves Cesbron (4509), David Laurin (249606), Tatiana Raskovalova (3132918), Claire Vettier (3132924), Martine Pernollet (3132915), Chantal Dumestre-Pérard (3122961), Giovanna Clavarino (164411), Noémie Delouche (3132921), Marie-Christine Jacob (2825870)   +8 more
core   +1 more source

Immunophenotypic portrait of leukemia‐associated‐phenotype markers in B acute lymphoblastic leukemia

Cytometry Part B: Clinical Cytometry, Volume 106, Issue 1, Page 45-57, January 2024.
Abstract Background Multiparametric flow cytometry (MFC) is an essential diagnostic tool in B acute lymphoblastic leukemia (B ALL) to determine the B‐lineage affiliation of the blast population and to define their complete immunophenotypic profile. Most MFC strategies used in routine laboratories include leukemia‐associated phenotype (LAP) markers ...
Emilia Boris, Alexandre Theron, Valentin Montagnon, Nicolas Rouquier, Marion Almeras, Jérôme Moreaux, Caroline Bret   +6 more
wiley   +1 more source

Relative expression patterns of 17 B-cell markers based on median fluorescence intensities (MFI).

, 2016
Means of MFI of three stage 1 or 2 hematogone samples, nine transitional B cell samples, twelve naive B cell samples, three germinal center B cell samples, nine memory B cell samples, six plasma cell samples are represented.
Jean-Yves Cesbron (4509), David Laurin (249606), Tatiana Raskovalova (3132918), Claire Vettier (3132924), Martine Pernollet (3132915), Chantal Dumestre-Pérard (3122961), Giovanna Clavarino (164411), Noémie Delouche (3132921), Marie-Christine Jacob (2825870)   +8 more
core   +1 more source

Graphical representation of the frequency (mean ± SD) of each stage of B-cell differentiation identified in the different types of samples.

, 2016
Samples of different anatomical sites (bone marrow, peripheral blood, lymph node and cord blood) were stained with the antibody combination of tube 1 of the panel and analyzed with the gating strategy shown in Fig 2 in order to identify ten B-cell ...
Jean-Yves Cesbron (4509), David Laurin (249606), Tatiana Raskovalova (3132918), Claire Vettier (3132924), Martine Pernollet (3132915), Chantal Dumestre-Pérard (3122961), Giovanna Clavarino (164411), Noémie Delouche (3132921), Marie-Christine Jacob (2825870)   +8 more
core   +1 more source

Is it Leukemia or Hematogone? (Case Report)

, 2018
B-lymphocyte progenitor cells, so-called hematogones, and mature B lymphocytes are normal bone marrow constituents, which are more prominent in the pediatric bone marrow.
Turhan, Ayse Bozkurt, Uygun, Basak, BÖR, ÖZCAN   +2 more
core   +1 more source

Hematogones in patients with acute myeloid leukaemia: Prognostic value and correlation with minimal residual disease

Leukemia Research Reports, 2021
Rita Tavarozzi, Enrica Manzato, Riccardo Morganti, Paola Sammuri, Giulia Tarrini, Federica Ricci, Giordana Mattana, Sara Galimberti, Mario Petrini, Giovanni Carulli   +9 more
doaj   +1 more source

Kinetics of hematogones in bone marrow samples from patients with non-Hodgkin lymphomas treated with rituximab-containing regimens: a flow cytometric study

, 2015
Treatment with rituximab, either alone or in combination with antiblastic drugs, causes significant depletion of circulating B-lymphocytes and modifications of B cell maturation in the bone marrow.
OTTAVIANO, VIRGINIA, CIABATTI, ELENA, Domenichini, C, Rousseau, M, GUERRI, VALENTINA, CARULLI, GIOVANNI, PETRINI, MARIO, Sammuri, P, Ciancia, Em   +8 more
core  

Comparative analysis carried out through histograms of CD10 and CD19 fluorescence intensity in leukemic blasts and hematogones

, 2005
HematogÃnias sÃo cÃlulas jovens normais da medula Ãssea responsÃveis pela produÃÃo das cÃlulas de linhagem B do sistema imunolÃgico. A leucemia linfoblÃstica aguda de cÃlulas precursoras B representa um dos tipos de transformaÃÃo neoplÃsica das ...
Jesamar Correia Matos
core  

CD19 expression on bone marrow hematogones and blasts following anti cd19 therapy in B-ALL a desriptive single center analysis

CD19 expression on bone marrow hematogones and blasts following anti cd19 therapy in B-ALL a desriptive single center ...
sica simona
core